EMA suspends, recalls AbbVie and Biogen’s doomed MS drug Zinbryta

Less than a week after announcing that they were “urgently reviewing” AbbVie and Biogen's multiple sclerosis drug Zinbryta on safety concerns, European regulators are recommending an immediate suspension and recall of the product.Original Article